Jump to main content
Jump to site search

Issue 2, 2016
Previous Article Next Article

Oligomycins as inhibitors of K-Ras plasma membrane localisation

Author affiliations

Abstract

Frequently present in pancreatic, colorectal and non-small cell lung carcinomas, oncogenic mutant K-Ras must be localised to the plasma membrane (PM) to be functional. Inhibitors of K-Ras PM localisation are therefore putative cancer chemotherapeutics. By screening a microbial extract library in a high content cell-based assay we detected the rare oligomycin class of Streptomyces polyketides as inhibitors of K-Ras PM localisation. Cultivation and fractionation of three unique oligomycin producing Streptomyces strains yielded oligomycins A–E (1–5) and 21-hydroxy-oligomycin A (6), together with the new 21-hydroxy-oligomycin C (7) and 40-hydroxy-oligomycin B (8). Structures for 1–8 were assigned by detailed spectroscopic analysis. Cancer cell viability screening confirmed 1–8 were cytotoxic to human colorectal carcinoma cells (IC50 > 3 μM), and were inhibitors of the ABC transporter efflux pump P-glycoprotein (P-gp), with 5 being comparable in potency to the positive control verapamil. Significantly, oligomycins 1–8 proved to be exceptionally potent inhibitors of K-Ras PM localisation (Emax 0.67–0.75 with an IC50 ∼ 1.5–14 nM).

Graphical abstract: Oligomycins as inhibitors of K-Ras plasma membrane localisation

Back to tab navigation

Supplementary files

Publication details

The article was received on 28 Sep 2015, accepted on 03 Nov 2015 and first published on 04 Nov 2015


Article type: Paper
DOI: 10.1039/C5OB02020D
Author version available: Download Author version (PDF)
Citation: Org. Biomol. Chem., 2016,14, 711-715
  •   Request permissions

    Oligomycins as inhibitors of K-Ras plasma membrane localisation

    A. A. Salim, L. Tan, X.-C. Huang, K.-J. Cho, E. Lacey, J. F. Hancock and R. J. Capon, Org. Biomol. Chem., 2016, 14, 711
    DOI: 10.1039/C5OB02020D

Search articles by author

Spotlight

Advertisements